RBC count in endurance athletes

RBC Count in Endurance Athletes: What Your Blood Test Is Actually Telling You

Introduction

In my physically active patients, one of the most important basic laboratory tests is the basic or complete blood count, with particular attention given to red blood cell–related parameters, as these are closely linked to oxygen transport and, by extension, physical performance.

What looks like a problem on paper is often something else entirely in a trained endurance athlete. Interpreting RBC count in an athletic population requires a fundamentally different framework — one that accounts for the hematological remodeling that sustained endurance training produces. This is particularly important when interpreting RBC count in endurance athletes, where standard reference ranges may not reflect physiological reality.

I wrote this article to unpack the physiology behind RBC count changes in endurance athletes, what those numbers mean for oxygen delivery and performance, and how clinicians, coaches, and athletes should approach blood test interpretation in this context.

RBC Count in Endurance Athletes: The Paradox of Lower Values and Higher Oxygen Capacity

The most counterintuitive finding in endurance athlete hematology is this: trained endurance athletes may show a lower RBC count and a lower hematocrit on routine CBC than sedentary individuals, even though total hemoglobin mass and total oxygen-carrying capacity are often increased — because endurance training expands both plasma volume and red cell mass, with plasma volume rising more [1].

This apparent contradiction resolves when you understand what drives the lower RBC count. Research consistently demonstrates that RBC count and hematocrit decrease in parallel with cumulative endurance training volume — and this decrease is attributable predominantly to plasma volume expansion, not to a loss of red cell mass [1][2].

A study examining 59 sedentary male subjects, 78 amateur, and 80 professional cyclists found that RBC count and hemoglobin were decreased in both athlete cohorts compared to sedentary subjects, with the reduction inversely associated with training volume in multivariate analysis [2]. Critically, this was not a sign of pathology — it was a signature of adaptation.

Plasma volume (PV) expands rapidly in response to endurance training, driven by aldosterone-dependent renal sodium reabsorption and water retention stimulated by antidiuretic hormone. Review data from 18 investigations found that PV and total blood volume increased rapidly after training sessions, while red cell volume remained unchanged for several days before beginning to increase [1]. The net effect is a dilutional reduction in RBC concentration, even as absolute red cell mass climbs over weeks of training.

The term historically applied to this phenomenon — “sports anemia” — is a misnomer. It is more accurately called pseudoanemia or dilutional pseudoanemia. Trained athletes have, in fact, an increased total mass of red blood cells and hemoglobin in circulation relative to sedentary individuals [1][3].

My physically active patients are often concerned about low hemoglobin levels. In reality, however, they frequently have a higher total hemoglobin mass, even if concentration-based values appear low on routine testing. This is not something we can easily measure in everyday clinical practice, as without more specialized methods, we do not have direct information about total blood volume. We therefore rely on indirect markers — particularly iron parameters — to guide interpretation. If iron status is normal, iron deficiency anemia is unlikely.

How Endurance Training Remodels the RBC Population

The changes in RBC count are only part of the story. Endurance training simultaneously reshapes the quality of circulating red blood cells in ways that are physiologically advantageous.

Accelerated RBC Turnover and a Younger Cell Population

Under normal conditions, red blood cells have a lifespan of approximately 120 days [4]. In distance runners, this is dramatically shortened. One analysis found the mean RBC lifespan in male distance runners to be approximately 67 days, and in female runners approximately 72 days — compared to 113 and 114 days respectively in sedentary controls [5]

This increase in RBC turnover is driven by a combination of enhanced red cell destruction and compensatory production. Mechanical stress (such as footstrike and intramuscular compression), oxidative stress, and osmotic changes during exercise all contribute to increased hemolysis, while exercise-induced hypoxic signaling stimulates erythropoietin release and bone marrow erythropoiesis. A long-lasting training regime can induce this increment in RBC turnover, resulting in a higher proportion of younger RBCs in trained individuals [3].

This accelerated turnover is not purely damaging — it is, in large part, adaptive. Younger RBCs have improved deformability and oxygen-release characteristics, higher glycolytic rates, and better antioxidant protection [3]. These properties translate directly into more efficient oxygen delivery to working muscle. This shift toward a younger red blood cell population may also be reflected as a slight increase in mean corpuscular volume (MCV), as reticulocytes are larger than mature red blood cells; however, in practice, this effect is typically small and MCV often remains within the normal range.

A 6-week endurance training program was found to produce a significant increase in the proportion of young RBCs alongside improved aerobic performance and improved overall RBC deformability in previously untrained participants [6]. Highly trained endurance athletes consistently exhibit a younger RBC population with improved deformability compared to the general population [6].

In my physically active patients, iron demands are often higher, largely due to increased red blood cell turnover, as well as exercise-induced hemolysis and the demands of ongoing erythropoiesis. As a result, many will at some point require iron supplementation. For this reason, I also tend to aim for a higher iron store target, typically reflected by ferritin levels above approximately 50 µg/L, particularly in symptomatic athletes or those with high training volumes. This threshold is commonly used in sports medicine as a practical benchmark [11], although optimal targets may vary depending on the individual and clinical context.

Erythropoiesis: The Compensatory Drive

The same training stress that accelerates RBC destruction also stimulates the production of new cells. Exercise-induced hypoxia activates hypoxia-inducible factor (HIF) signaling, which drives erythropoietin (EPO) release from the kidneys and stimulates bone marrow erythropoiesis [1]. Reticulocyte counts — the immature red cells newly released from the marrow — can rise within 1–2 days of endurance training [1], reflecting active compensatory production. At sea level, however, sustained EPO elevation following normoxic training is inconsistent; erythropoietic stimulation occurs but the magnitude is substantially lower and more variable than under hypoxic conditions [1].

In athletes undertaking altitude training — the most potent physiological stimulus for erythropoiesis — EPO concentrations increase significantly from the first hours of hypoxic exposure, with maximal reticulocytosis typically occurring around 8–10 days at moderate altitude [7]. Several weeks of altitude training can raise hemoglobin concentration by a few percent (broadly in the low single-digit percentage range), with the exact response varying considerably by individual athlete and protocol [7]. The result, regardless of setting, is a circulatory system continuously supplied with a rejuvenated RBC workforce.

EPO is unfortunately well known to many Finns. In 2001, a major doping scandal in Finland involved cross-country skiers using EPO. The aim was specifically to enhance erythropoiesis and thereby increase total hemoglobin mass through increased red blood cell production.

What Drives RBC Destruction in Endurance Athletes

Understanding why RBC counts behave the way they do requires examining the mechanisms of accelerated red cell loss.

Mechanical destruction of RBCs during running — historically termed footstrike hemolysis — is a well-documented phenomenon. Footstrike has been identified as the major contributor to hemolysis during running, with plasma free hemoglobin rising significantly more during treadmill running than during equivalent-intensity cycling [8]. However, the clinical significance of this destruction appears limited in modern athletes. A scoping review of 267 long-distance runners found that reticulocyte count increased 16% and haptoglobin decreased 21% following races, but hemoglobin, hematocrit, and RBC count values remained within accepted normal limits [9].

In my clinical experience, footstrike hemolysis typically goes largely unnoticed. The effect is usually small, it rarely leads to clinically significant anemia, and I seldom measure hemolysis markers in routine settings.

The evidence also suggests that hemolysis is not exclusive to foot-impact sports. Exercise-induced hemolysis has been documented in swimmers and cyclists as well, pointing to additional mechanisms including intramuscular compression, osmotic stress, and oxidative damage to RBC membranes [1].

RBCs are also highly vulnerable to oxidative damage. They are continuously exposed to oxygen and carry high concentrations of polyunsaturated fatty acids and heme iron. During high-intensity training, oxidative stress proportional to oxygen uptake can deplete antioxidant systems in RBCs, impairing their deformability and shortening their functional lifespan [4]. This is a key reason why nutritional adequacy — particularly antioxidant status — matters in athletes undergoing heavy training loads.

Interpreting RBC Count in Endurance Athletes: Practical Clinical Approach

Standard laboratory reference ranges are generated from general population data. Applying these ranges to endurance athletes introduces systematic misinterpretation. Research shows that population-based reference ranges may be of limited value in athletes, and that plasma volume expansion can lead to misleading concentration-based results [2][10].

What a “Low” RBC Count Usually Means

In an asymptomatic, well-trained endurance athlete in a normal training phase, a mildly reduced RBC count should first be interpreted as plasma volume expansion — dilutional pseudoanemia — rather than true red cell deficiency [3]. This distinction matters clinically: dilutional pseudoanemia does not require treatment, normalizes as plasma volume adaptation recedes with detraining, and is associated with the beneficial hemodynamic effects of a lower-viscosity, higher-volume circulatory system [1].

True anemia — reflecting insufficient total red cell mass — requires additional markers to diagnose. For distinguishing dilution from true red-cell deficit in elite sport settings, measurement of total hemoglobin mass (tHbmass) is highly informative when available, as it directly accounts for plasma volume changes [1].

In reality, however, tHbmass measurement is rarely available in most clinics and is typically limited to specialized centers or research environments — at least in Finland. In practice, interpretation relies on combining RBC count with hemoglobin concentration and iron-related markers such as ferritin and reticulocyte indices to build a more complete picture.

What a ”High” RBC Count Might Mean

A high RBC count should also be interpreted with caution. In many cases, it reflects hemoconcentration rather than a true increase in red cell mass, for example due to dehydration or recent exercise. In these situations, plasma volume is reduced, making RBC values appear elevated. 

I generally approach these situations with caution, and I often review previous results or repeat the test before drawing conclusions. Hemoglobin rarely rises to significantly elevated levels without an underlying reason, so unexpected findings should always be interpreted in context.

Less commonly, an elevated RBC count reflects a true increase in red cell mass, typically driven by hypoxia-induced erythropoiesis (such as altitude exposure, sleep apnea, or chronic lung disease) or, more rarely, pathological conditions such as polycythemia vera. As with low values, interpretation should always consider hemoglobin, hematocrit, hydration status, and the broader clinical context.

Summary

Red blood cell values in endurance athletes are frequently misinterpreted when viewed through standard population-based reference ranges. Lower RBC count, hemoglobin, or hematocrit often reflect plasma volume expansion rather than true anemia, with total hemoglobin mass and oxygen-carrying capacity commonly preserved or even increased.

Endurance training induces a range of hematological adaptations, including increased plasma volume, accelerated red blood cell turnover, and a shift toward a younger, more deformable red blood cell population. These changes support efficient oxygen delivery but can complicate the interpretation of routine laboratory results.

Accurate assessment therefore requires a contextual approach, incorporating training status, symptoms, and additional markers such as ferritin, reticulocyte indices, and other hematological parameters. Both low and high RBC values should be interpreted with caution, as they may reflect physiological adaptation, transient changes in plasma volume, or, less commonly, underlying pathology.

A physiology-informed interpretation helps avoid unnecessary investigations while ensuring that clinically relevant abnormalities are appropriately identified and managed.

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC3824146/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC7927508/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC8472039/
  4. https://pubmed.ncbi.nlm.nih.gov/7740249/
  5. https://atm.amegroups.org/article/view/25989/html
  6. https://www.sciencedirect.com/science/article/pii/S2095254619300225
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC5904371/
  8. https://journals.physiology.org/doi/full/10.1152/japplphysiol.00631.2001
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC11698231/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC6901403/
  11. https://smw.ch/index.php/smw/article/view/2087/3053

Similar Posts